ENOV
Enovis Sets Stage for Explosive Growth in 2025
Enovis, a high-value medtech growth company, recently reported its fourth quarter 2024 earnings, revealing a transformative year that has set the stage for explosive growth in 2025. The company's Chair and Chief Executive Officer, Matthew Trerotola, expressed excitement about the future of Enovis during the conference call, citing